Stay updated on M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Sign up to get notified when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added and v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T20:54:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page no longer displays a government funding lapse notice and related status updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:16:26.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Core study details and primary actions appear unchanged. Any observed differences seem limited to formatting or minor wording edits.
    Difference
    0.4%
    Check dated 2025-11-03T13:10:26.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-06T01:47:08.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page has shifted from broad solution/pharmaceutical categories to a more detailed chemical- and compound-focused taxonomy, with an updated version tag (v3.1.0).
    Difference
    1.0%
    Check dated 2025-09-28T23:25:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:58.000Z thumbnail image

Stay in the know with updates to M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.